| 产品描述: | Sulfopin (PIN1-3) is a highly selective covalent inhibitor of Pin1 with an apparent Ki of 17 nM. Sulfopin blocks Myc-driven tumors in vivo. The peptidyl-prolyl isomerase, Pin1, is exploited in cancer to activate oncogenes and inactivate tumor suppressors |
| 体外研究: |
MDA-MB-468 细胞对 SuLfopin 表现出最显著的敏感性 (1、2.5 μM;4-8 天)。 SuLfopin (2 μM,HEK293 细胞;48 小时) 下调 Myc 转录。 SuLfopin (1、2.5 μM;PATU-8988T 细胞;4 天) 显示合成 (S) 期细胞数量小幅但显着减少,生长 1 (G1) 期细胞相应增加。 Cell Proliferation Assay Cell Line: Kuramochi, MDA-MB-468, NGP, NBL-S, MDA-MB-468 cells Concentration: 1, 2.5 μM Incubation Time: 4,6, 8 days Result: Showed variation in antiproliferative effects across cancer cell lines Kuramochi, MDA-MB-468, NGP and NBL-S, with the most pronounced sensitivity observed in MDA-MB-468 cells. |
| 体内研究: |
SuLfopin (40 mg/kg; p.o.; QD/BID for 7 days) 使小鼠神经母细胞瘤消退。 SuLfopin (20-40 mg/kg; i.p.; daily for 27 days) 抑制小鼠胰腺癌的进展。 SuLfopin (25-100 μM) 可阻断斑马鱼的神经母细胞瘤。 Animal Model: Transgenic Th-MYCN mice Dosage: 40 mg/kg Administration: Once a day (QD) or twice a day (BID) for 7 days Result: Sulfopin-treated QD mice showed a significant average increase in survival of 10 days, while Sulfopin-treated BID mice showed an even more pronounced average increase of 28 days. |
| 参考文献: |
1. Dubiella C, et al. Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo. Nat Chem Biol. 2021;17(9):954-963. |
| 溶解性: |
Soluble in DMSO、H2O |
| 保存条件: |
-20℃ |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
0 ml |
0 ml |
0 ml |
| 5 mM |
0 ml |
0 ml |
0 ml |
| 10 mM |
0 ml |
0 ml |
0 ml |
| 50 mM |
0 ml |
0 ml |
0 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |